Is Tirzepatide a GLP-1? It Is a GLP-1 and a GIP
Last updated November 5, 2026
Short answer: Yes. Tirzepatide is a GLP-1 receptor agonist, and it is also a GIP receptor agonist, which is why it is called a dual agonist. Semaglutide (Ozempic, Wegovy) activates only the GLP-1 receptor.
GLP-1 or GIP? Both
| Medication | Brand names | Receptors it activates |
|---|---|---|
| Tirzepatide | Mounjaro (type 2 diabetes), Zepbound (weight management) | GIP and GLP-1 |
| Semaglutide | Ozempic (type 2 diabetes), Wegovy (weight management) | GLP-1 only |
The Zepbound label describes tirzepatide as a GIP receptor and GLP-1 receptor agonist. The Wegovy label describes semaglutide as a GLP-1 receptor agonist. Neither label mentions GLP-2, so tirzepatide is not a GLP-2 drug.
Is tirzepatide the same as GLP-1?
Not exactly. GLP-1 and GIP are both natural gut hormones released after eating, and each affects insulin release and appetite signaling. Tirzepatide is a medicine engineered to activate the receptors for both. Because it acts on GLP-1, people commonly group it with GLP-1 medications, and it is fair to call it a GLP-1 medication. It is just not only a GLP-1 medication.
What "dual agonist" means
An agonist is a drug that switches a receptor on. Tirzepatide switches on two: the GLP-1 receptor and the GIP receptor. The label notes that both are found in areas of the brain involved in appetite regulation.
Mounjaro and Zepbound are both tirzepatide
Zepbound is approved for weight management and Mounjaro for type 2 diabetes, and both contain tirzepatide. See Mounjaro vs. Zepbound for the differences.
How it differs from semaglutide
In the head-to-head SURMOUNT-5 trial in adults with obesity, tirzepatide produced 20.2% average weight loss versus 13.7% for semaglutide at 72 weeks. Researchers often attribute part of the difference to the dual mechanism, though the drugs also differ in other ways. See the full semaglutide vs. tirzepatide comparison.
Should you use them together?
No. The Zepbound label says that using it together with other tirzepatide-containing products or with any GLP-1 receptor agonist is not recommended.
See the full GLP-1 medications list and what GLP-1 is.
Sources
See timelines for both medications side by side.
Try the Free GLP-1 CalculatorMedical Disclaimer
This calculator is for educational and informational purposes only and does not provide medical advice, diagnose any condition, recommend or prescribe treatment, or guarantee results. Estimates are based on information you provide and published clinical-trial averages. Individual results can vary significantly.
Estimates are based on average outcomes reported in the STEP 1 (semaglutide) and SURMOUNT-1 (tirzepatide) clinical trials. Individual results can vary significantly and are influenced by factors such as dosage, diet, and adherence.
Do not start, stop, or change any medication based on the results of this calculator. Always consult a qualified healthcare professional regarding medications, treatment options, risks, side effects, and your individual health needs.
